Company Filing History:
2 out of 4,455 
2 out of 15,475 
Years Active: 2022-2025
Title: Dharmaraj Samuel: Innovator in Cancer Treatment
Introduction
Dharmaraj Samuel is a notable inventor based in Dublin, CA, who has made significant contributions to the field of cancer treatment. With a focus on innovative methods utilizing antibodies, he has been awarded 2 patents for his groundbreaking work.
Latest Patents
Samuel's latest patents include a method of treating cancer using anti-AV8 antibodies. This invention provides antibodies and antigen-binding fragments that specifically bind to αvβ8 integrin. The invention encompasses various uses and associated methods of employing these antibodies. Another significant patent is for anti-AVB8 antibodies and compositions, which also specifically bind to αvβ8 integrin, including their uses and methods.
Career Highlights
Throughout his career, Dharmaraj Samuel has worked with prominent organizations such as Pfizer Corporation and the University of California. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer treatment.
Collaborations
Some of his notable coworkers include Kyle Steven Niessen and Charles Ray Holst, who have collaborated with him on various projects.
Conclusion
Dharmaraj Samuel's contributions to cancer treatment through his patented inventions highlight his role as a leading innovator in the field. His work continues to inspire advancements in medical research and treatment methodologies.